Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Cell phenotype determines PAI-1 antiproliferative effect - suppressed proliferation of the lung cancer but not prostate cancer cells].

Pneumonologia i alergologia polska - 1 Jan 2010

Chorostowska-Wynimko Joanna, Kedzior Marta, Struniawski Radosław, Jaguś Paulina, Skrzypczak-Jankun Ewa, Jankun Jerzy

Abstract excerpt

INTRODUCTION: Plasminogen inhibitor activator type 1 (PAI-1) is an important regulator of tumor growth and metastasis formation acting directly via specific urokinase complexing or indirectly due to its affinity to vitronectin. We have shown previously that PAI-1 modifies angiogenic activity of e...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Proliferation
Share to Cell Transformation, Neoplastic
Share to Dose-Response Relationship, Drug

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Plasminogen Activator Inhibitor 1

Share to Prostatic Neoplasms

Share to Serine Proteinase Inhibitors

Share to Tumor Cells, Cultured

Share to Urokinase-Type Plasminogen Activator

Source

Identifiers

PMID: 20665448

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20665448-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Cell phenotype determines PAI-1 antiproliferative effect - suppressed proliferation of the lung cancer but not prostate cancer cells].PMID 20665448Read ↗

The plasminogen activator inhibitor-1 paradox in cancer: a mechanistic understanding.Semantic proximity Read ↗

Unexpected Role of Plasminogen Activator Inhibitor 1 in Cell Adhesion and DetachmentSemantic proximity Read ↗

Historical analysis of PAI-1 from its discovery to its potential role in cell motility and diseaseSemantic proximity Read ↗

Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells.Semantic proximity Read ↗

Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner.Semantic proximity Read ↗

Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 prostate cancer cell line.Semantic proximity Read ↗

Structure-function relationships of plasminogen activator inhibitor-1 and its potential as a therapeutic agent.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 and tumour growth, invasion, and metastasisSemantic proximity Read ↗

Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cellsSemantic proximity Read ↗

The urokinase-type plasminogen activator system in cancer metastasis: A reviewSemantic proximity Read ↗

Human Protease-Activated Receptor 1 Expression in Malignant EpitheliaSemantic proximity Read ↗

Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells In Vitro.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.